Insider Trading History of Freeman Kevin D

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Freeman Kevin D since 2015. This trader's CIK number is 1522478. At the time of last reporting, Freeman Kevin D was the Officer of Galectin Therapeutics Inc. (stock ticker symbol GALT). Also see all insider trading activities at Galectin Therapeutics Inc.


Yearly summary of insider trading at Galectin Therapeutics Inc (GALT) by Freeman Kevin D

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 GALT 5,000 $14,495 0 $0 0 $0
2024 GALT 15,000 $40,400 0 $0 0 $0
2022 GALT 25,000 $39,105 0 $0 0 $0
2021 GALT 25,000 $67,757 0 $0 0 $0
2020 GALT 11,000 $22,696 0 $0 0 $0
2019 GALT 15,426 $62,756 0 $0 0 $0
2018 GALT 4,000 $16,384 0 $0 0 $0
2017 GALT 8,400 $13,725 0 $0 0 $0
2015 GALT 2,083 $5,624 0 $0 0 $0


Insider trading of Galectin Therapeutics Inc (GALT) by Freeman Kevin D

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-07-17 GALT Buy 5,000 2.90 14,495
2024-10-16 GALT Buy 10,000 2.70 27,000
2024-06-20 GALT Buy 2,500 2.38 5,950
2024-04-22 GALT Buy 2,500 2.98 7,450
2022-10-28 GALT Buy 10,000 1.41 14,100
2022-05-19 GALT Buy 5,000 1.33 6,650
2022-04-18 GALT Buy 5,000 1.71 8,550
2022-01-19 GALT Buy 5,000 1.96 9,805
2021-12-06 GALT Buy 5,000 2.28 11,399
2021-12-06 GALT Buy 5,000 2.34 11,700
2021-10-29 GALT Buy 2,000 3.17 6,340
2021-10-21 GALT Buy 2,000 3.19 6,380
2021-10-19 GALT Buy 3,000 3.37 10,107
2021-09-23 GALT Buy 3,000 3.88 11,631
2021-04-05 GALT Buy 5,000 2.04 10,200
2020-09-04 GALT Buy 5,000 2.57 12,850
2020-03-19 GALT Buy 6,000 1.64 9,846
2019-11-15 GALT Buy 3,000 3.36 10,077
2019-09-06 GALT Buy 1,290 3.71 4,785
2019-05-31 GALT Buy 9,136 4.28 39,102
2019-04-05 GALT Buy 500 4.73 2,365
2019-02-08 GALT Buy 1,500 4.29 6,427
2018-02-01 GALT Buy 2,000 4.10 8,192
2018-02-01 GALT Buy 2,000 4.10 8,192
2017-12-07 GALT Buy 8,400 1.63 13,725
2015-06-01 GALT Buy 2,083 2.70 5,624

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Freeman Kevin D (Officer of Galectin Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.